Clinical trial
Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During…
NCT00142909 · Yale University, Other · Completed
Key facts
| NCT number | NCT00142909 |
|---|---|
| Title | Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1 |
| Official title | Lofexidine: Enhancing Naltrexone Treatment for Opiate Addiction |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | Lofexidine, Placebo |
| Enrollment | 86 |
| Start date | Feb 1, 2005 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Sep 2, 2005 |
| Last update posted | Jul 30, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: